The Role of Macrophage Migration Inhibitory Factor in Mouse Islet Transplantation

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Transplantation

• Publication date

  2008-11-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/TP.0b013e31818bdbefPMID 19034004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Magnetic Resonance Imaging of Pancreatic Islet Grafts After Iron Nanoparticle Labeling

  2008cited by this paper
• The Caspase Selective Inhibitor EP1013 Augments Human Islet Graft Function and Longevity in Marginal Mass Islet Transplantation in Mice

  2008cited by this paper
• Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex*

  2008influential reference
• The role of macrophage migration inhibitory factor on glucose metabolism and diabetes

  2008cited by this paper
• Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus

  2008cited by this paper
• Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.

  2008cited by this paper
• MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

  2007cited by this paper
• Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.

  2007cited by this paper
• The Proinflammatory Cytokine Macrophage Migration Inhibitory Factor Regulates Glucose Metabolism during Systemic Inflammation1

  2007cited by this paper
• Caspase Inhibitor Therapy Enhances Marginal Mass Islet Graft Survival and Preserves Long-Term Function in Islet Transplantation

  2007cited by this paper
• This information is current as Macrophage Migration Inhibitory Factor Expression and Function by Endogenous Regulation of IL-1 and TNF Receptor

  2006cited by this paper
• Autoimmunity after islet-cell allotransplantation.

  2006cited by this paper
• Role for macrophage migration inhibitory factor in asthma.

  2005cited by this paper
• Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft

  2005cited by this paper
• Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.

  2005cited by this paper
• PANCREAS TRANSPLANTATION: EFFECTS ON DIABETIC RETINOPATHY.

  2004cited by this paper
• Blockade of Macrophage Migration Inhibitory Factor Does Not Prevent Acute Renal Allograft Rejection

  2003cited by this paper
• Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4)

  2003cited by this paper
• CARDIAC ALLOGRAFT REJECTION IN THE ABSENCE OF MACROPHAGE MIGRATION INHIBITORY FACTOR

  2003cited by this paper
• Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation.

  2003cited by this paper
• Macrophage migration inhibitory factor: a regulator of innate immunity

  2003cited by this paper
• Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia.

  2002cited by this paper
• Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation.

  2002cited by this paper
• Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation.

  2002cited by this paper
• Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation.

  2001cited by this paper
• MIF regulates innate immune responses through modulation of Toll-like receptor 4

  2001cited by this paper
• IN VIVO BLOCKADE OF MACROPHAGE MIGRATION INHIBITORY FACTOR PREVENTS SKIN GRAFT DESTRUCTION AFTER INDIRECT ALLORECOGNITION1

  2001cited by this paper
• Protection from septic shock by neutralization of macrophage migration inhibitory factor

  2000cited by this paper
• Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis

  1999cited by this paper
• Up‐regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat

  1999cited by this paper
• Macrophage migration inhibitory factor expression in human renal allograft rejection.

  1998cited by this paper
• Migration inhibitory factor expression in experimentally induced endotoxemia.

  1997cited by this paper
• Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor.

  1997cited by this paper
• An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

  1996cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1995cited by this paper
• Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF).

  1994cited by this paper
• Effect of 15-Deoxyspergualin on Immediate Function and Long-Term Survival of Transplanted Islets in Murine Recipients of a Marginal Islet Mass

  1994cited by this paper
• The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor

  1994cited by this paper
• MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

  1993cited by this paper
• islet transplantation: implications for intrahepatic grafts

  year unknowncited by this paper

• Pancreas patch grafting to treat type 1 diabetes.

  2023cites this paper
• Assessing Islet Transplantation Outcome in Mice.

  2020cites this paper
• Tangshen formula improves inflammation in renal tissue of diabetic nephropathy through SIRT1/NF-κB pathway.

  2017cites this paper
• Inactivation of p27kip1 Promoted Nonspecific Inflammation by Enhancing Macrophage Proliferation in Islet Transplantation.

  2016cites this paper
• Advances in Local Drug Release and Scaffolding Design to Enhance Cell Therapy for Diabetes

  2015cites this paper
• α1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation

  2014cites this paper
• Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell

  2014cites this paper
• The Role of MIF in Type 1 and Type 2 Diabetes Mellitus

  2014cites this paper
• Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid‐induced apoptosis

  2012cites this paper
• Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine‐induced apoptosis in vitro

  2012cites this paper
• Macrophage migration inhibitory factor (MIF) enhances palmitic acid- and glucose-induced murine beta cell dysfunction and destruction in vitro

  2012cites this paper
• Inflammation-Mediated Regulation of MicroRNA Expression in Transplanted Pancreatic Islets

  2012cites this paper
• Beta cell function: the role of macrophage migration inhibitory factor

  2012cites this paper
• Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events

  2011cites this paper
• Immunosuppressive therapy in islet transplantation

  2011cites this paper
• Detecting Rejection after Mouse Islet Transplantation Utilizing Islet Protein-Stimulated ELISPOT

  2010cites this paper
• Liraglutide, a long‐acting human glucagon‐like peptide 1 analogue, improves human islet survival in culture

  2010cites this paper
• Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.

  2010cites this paper
• Immunological aspects of pancreatic islet cell transplantation

  2010cites this paper
• Strategies to counteract ß-cell loss in pancreatic islet transplantation

  2009cites this paper
• Histologic Graft Assessment After Clinical Islet Transplantation

  2009cites this paper